Maryline Gagnebin
Papers
1
Total Citations
363
H-Index
1
About
Maryline Gagnebin is a leading molecular biologist whose research bridges the critical gap between non-coding RNA regulation and human genetic variation. Her most influential work, a 2007 study with over 360 citations, revealed how human microRNA-155 on chromosome 21 differentially interacts with a polymorphic target in the AGTR1 3′ untranslated region. This landmark discovery provided the first mechanistic explanation for how functional single-nucleotide polymorphisms (SNPs) can alter miRNA binding and contribute to complex disease phenotypes, fundamentally advancing our understanding of post-transcriptional gene regulation. Gagnebin’s contributions have been instrumental in establishing the paradigm that genetic variants in miRNA target sites are not silent, but rather represent a key layer of regulatory variation underlying phenotypic diversity. Her work has had profound implications for cardiovascular genetics, hypertension research, and the broader field of personalized medicine, demonstrating how subtle sequence changes can dramatically impact gene expression networks. Through her rigorous integration of computational prediction with experimental validation, Gagnebin has set a gold standard for studying miRNA-SNP interactions, inspiring a generation of researchers to explore the regulatory consequences of human genome variation.
Research Focus
Key Achievements
Top Papers
- 1